Scholar Performance and Praxis Assessment in Children With Rolandic Epilepsy
Recruitment status was Active, not recruiting
Rolandic Epilepsy is the most common form of childhood epilepsy. It is classified as idiopathic, age-related epilepsy syndrome with benign evolution. The absence of neuropsychological impairment is part of the criteria of benignity of this epilepsy syndrome. However recently have been suggested several deficits related to attention and language. The purpose of this study was assess school performance and to investigate problems of praxis in patients with rolandic epilepsy as compared to a control group composed of normal children with age, gender and educational level equivalents.
|Study Design:||Observational Model: Cohort
Time Perspective: Retrospective
|Official Title:||Scholar Performance and Praxis Assessment in Children With Rolandic Epilepsy|
- Our data will indicate the group performance in tests of writing, arithmetic and reading. [ Time Frame: one year ] [ Designated as safety issue: No ]
- Another important aspect was the absence of orofacial apraxia in children with epilepsy. [ Time Frame: one year ] [ Designated as safety issue: No ]
|Study Start Date:||September 2009|
|Estimated Study Completion Date:||February 2011|
|Estimated Primary Completion Date:||February 2011 (Final data collection date for primary outcome measure)|
Patients older than seven years old with clinical and electroencephalographic diagnosis of Rolandic Epilepsy
Behavioral: Language Assessment
Patients underwent an assessment performed with School Performance Test, Syntactic Awareness Test and a Peabody Picture Vocabulary Test.
Other Name: Children with epilepsy, language impairment and dyslexia
Method: Nineteen patients aged between 7 and 12 years underwent clinical neurological evaluation, psychological assessment, through Weschsler Scales of Intelligence and language evaluation, to assess the academic performance and research of the presence or absence of praxis difficulties.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01046760
|Campinas, São Paulo, Brazil, 13041317|
|Study Chair:||Marilisa Guerreiro, doctor||University of Campinas, Brazil|